May 22, 2014
1 min read

Hydrophilic acrylic IOL shows high long-term safety profile for eyes with uveitis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

A hydrophilic acrylic IOL improved vision and maintained a good long-term safety profile in eyes with uveitis, according to a study.

The retrospective study included 171 eyes of 140 patients with uveitis who underwent phacoemulsification and implantation of a Rayner hydrophilic acrylic IOL. Mean patient age was 51 years. Mean follow-up was 3.8 years.

Uveal bioincompatibility was identified in 31 of 171 eyes. Visually insignificant deposits on the IOL were identified in 17 eyes (9.94%).

Capsule bioincompatability was identified in 107 eyes (62.57%); this occurred in 32 eyes (18.71%) at 3 months and in 42 eyes (24.56%) at 6 months.

Posterior capsule opacification developed in 102 eyes (59.65%) at a mean 15 months after surgery. Thirty-one eyes (18.13%) underwent Nd:YAG laser capsulotomy.

Corrected distance visual acuity was 6/12 or better in 72 of 102 eyes (70.59%) at 6 months, 98 eyes of 160 eyes at 1 year (61.25%) and 64 of 113 eyes (56.63%) at 3 years.

Eighty-five percent of eyes had corrected distance visual acuity of better than logMAR 0.3 or sustained a three-line improvement in vision at 1 year, the authors said.

Disclosure: The authors have no relevant financial disclosures.